Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Locher

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2005
Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?C Copie-Bergman, C Locher, M Levy, et al.
Cell Death and Differentiation|June 8, 2013
Contribution of humoral immune responses to the antitumor effects mediated by anthracyclinesD Hannani, C Locher, T Yamazaki, et al.
British Journal of Cancer|October 17, 2003
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderlyT Aparicio, J Desramé, T Lecomte, et al.
Revue Des Maladies Respiratoires|December 1, 2014
[Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians]D Debieuvre, C Locher, A-C Neidhardt, et al.
Revue De Pneumologie Clinique|December 21, 2010
[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010]M Grivaux, C Locher, P Bombaron, et al.
Cell Death and Differentiation|July 2, 2013
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonistsT Yamazaki, D Hannani, V Poirier-Colame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2010
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO studyA Zaanan, L Costes, M Gauthier, et al.
Revue Des Maladies Respiratoires|June 18, 2019
[Second- or third-line treatment with erlotinib in EGFR wild-type non-small cell lung cancer: Real-life data]D Debieuvre, L Moreau, M Coudert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 25, 2024
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world studyR Varnier, C Toullec, S Philonenko, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2005
Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?C Copie-Bergman, C Locher, M Levy, et al.
Cell Death and Differentiation|June 8, 2013
Contribution of humoral immune responses to the antitumor effects mediated by anthracyclinesD Hannani, C Locher, T Yamazaki, et al.
British Journal of Cancer|October 17, 2003
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderlyT Aparicio, J Desramé, T Lecomte, et al.
Revue Des Maladies Respiratoires|December 1, 2014
[Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians]D Debieuvre, C Locher, A-C Neidhardt, et al.
Revue De Pneumologie Clinique|December 21, 2010
[Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010]M Grivaux, C Locher, P Bombaron, et al.
Cell Death and Differentiation|July 2, 2013
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonistsT Yamazaki, D Hannani, V Poirier-Colame, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2010
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO studyA Zaanan, L Costes, M Gauthier, et al.
Revue Des Maladies Respiratoires|June 18, 2019
[Second- or third-line treatment with erlotinib in EGFR wild-type non-small cell lung cancer: Real-life data]D Debieuvre, L Moreau, M Coudert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 25, 2024
Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world studyR Varnier, C Toullec, S Philonenko, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Pageof 7